Thyrocare Technologies Ltd reported its unaudited financial results for the quarter and half year ended September 30, 2025, announced an interim dividend of ₹7 per share, a bonus issue of 2 fully paid shares for every 1 share held, and plans to increase authorized share capital from ₹100 crore to ₹300 crore.